Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Nanoscale. 2019 Aug 15;11(32):15326-15338. doi: 10.1039/c9nr05236d.
All-in-one nanoagents with a single-component and all-required functions have attracted increasing attention for the imaging-guided therapy of tumors, but the design and preparation of such nanoagents remain a challenge. Herein, we report the introduction of oxygen vacancies to traditional semiconductors with heavy-metal elements for tuning photoabsorption in the near infrared (NIR) region, by using Bi2WO6 (band-gap: ∼2.7 eV) as a model. Bi2WO6-x nanodots with sizes of ∼3 or ∼8 nm have been prepared by a facile coprecipitation-solvothermal method assisted by citric acid (CA, 0.1-1.5 g) as the reduction agent. CA confers the removal of O atoms from the [Bi2O2]2+ layer during the solvothermal process, resulting in the formation of plenty of oxygen vacancies in the Bi2WO6-x crystal. As a result, NIR photoabsorption of Bi2WO6-x nanodots can be remarkably enhanced with the increase of the CA amount from 0 to 1.0 g. Under irradiation of a single-wavelength (808 nm, 1.0 W cm-2) NIR laser, black Bi2WO6-x-CA1.0 nanodots can not only efficiently produce a sufficient amount of heat with a photothermal conversion efficiency of 45.1% for photothermal therapy, but also generate singlet oxygen (1O2) for photodynamic therapy. Furthermore, due to the presence of heavy-metal (Bi and W) elements, Bi2WO6-x-CA1.0 nanodots have high X-ray attenuation ability for CT imaging. After the Bi2WO6-x-CA1.0 nanodot dispersion is injected into the tumor-bearing mice, the tumor can be imaged by using CT and an IR thermal camera. After irradiation with a single-wavelength (808 nm, 1.0 W cm-2, 10 min) NIR laser, the tumor can be completely suppressed by the synergic photothermal and photodynamic effects of Bi2WO6-x-CA1.0 nanodots, without recurrence and treatment-induced toxicity. Therefore, Bi2WO6-x nanodots have great potential as a novel all-in-one nanoagent for the imaging and phototherapy of tumors.
具有单一成分和所有必需功能的一体化纳米制剂在肿瘤的成像引导治疗中受到了越来越多的关注,但这种纳米制剂的设计和制备仍然是一个挑战。在此,我们报告了在传统的重金属半导体中引入氧空位来调节近红外(NIR)区域的光吸收,以 Bi2WO6(带隙:2.7 eV)为模型。通过使用柠檬酸(CA,0.1-1.5 g)作为还原剂的简便共沉淀-溶剂热法制备了尺寸约为3 或~8 nm 的 Bi2WO6-x 纳米点。CA 在溶剂热过程中使[Bi2O2]2+层中的 O 原子去除,从而在 Bi2WO6-x 晶体中形成大量氧空位。结果,随着 CA 用量从 0 增加到 1.0 g,Bi2WO6-x 纳米点的 NIR 光吸收可以显著增强。在单波长(808nm,1.0W/cm2)NIR 激光照射下,黑色 Bi2WO6-x-CA1.0 纳米点不仅可以高效地产生足够的热量,光热转换效率为 45.1%,用于光热治疗,而且还可以产生用于光动力治疗的单线态氧(1O2)。此外,由于存在重金属(Bi 和 W)元素,Bi2WO6-x-CA1.0 纳米点具有高 X 射线衰减能力,可用于 CT 成像。将 Bi2WO6-x-CA1.0 纳米点分散体注入荷瘤小鼠后,可使用 CT 和红外热像仪对肿瘤进行成像。用单波长(808nm,1.0W/cm2,10min)NIR 激光照射后,Bi2WO6-x-CA1.0 纳米点的协同光热和光动力作用可完全抑制肿瘤,无复发且无治疗诱导的毒性。因此,Bi2WO6-x 纳米点具有作为肿瘤成像和光疗的新型一体化纳米制剂的巨大潜力。